BLINCYTO (blinatumomab)
ANTINEOPLASTIC - IMMUNOTHERAPY, T-CELL ENGAGER · B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA ·+1
AMGEN
All drugs.
Search drugs by brand or generic name, or refine the directory by prescription status, class, indication, manufacturer, and specialty.
Enter at least 3 characters to search the full directory.
Results
BLINCYTO (blinatumomab)
ANTINEOPLASTIC - IMMUNOTHERAPY, T-CELL ENGAGER · B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA ·+1
AMGEN
BLINCYTO (blinatumomab)
ANTINEOPLASTIC - IMMUNOTHERAPY, T-CELL ENGAGER · B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA ·+1
AMGEN
KIMMTRAK (tebentafusp-tebn)
ANTINEOPLASTIC - IMMUNOTHERAPY, T-CELL ENGAGER · UVEAL MELANOMA IN HLA-A *02:01 POSITIVE PATIENT
IMMUNOCORE COMM
TECVAYLI (teclistamab-cqyv)
ANTINEOPLASTIC - IMMUNOTHERAPY, T-CELL ENGAGER · MULTIPLE MYELOMA
JANSSEN BIOTECH, Inc.
LUNSUMIO (mosunetuzumab-axgb)
ANTINEOPLASTIC - IMMUNOTHERAPY, T-CELL ENGAGER · FOLLICULAR LYMPHOMA
GENENTECH
EPKINLY (epcoritamab-bysp)
ANTINEOPLASTIC - IMMUNOTHERAPY, T-CELL ENGAGER · FOLLICULAR LYMPHOMA ·+1
GENMAB US, INC.
COLUMVI (glofitamab-gxbm)
ANTINEOPLASTIC - IMMUNOTHERAPY, T-CELL ENGAGER · DIFFUSE LARGE B-CELL LYMPHOMA
GENENTECH
TALVEY (talquetamab-tgvs)
ANTINEOPLASTIC - IMMUNOTHERAPY, T-CELL ENGAGER · MULTIPLE MYELOMA
JANSSEN BIOTECH, Inc.
ELREXFIO (elranatamab-bcmm)
ANTINEOPLASTIC - IMMUNOTHERAPY, T-CELL ENGAGER · MULTIPLE MYELOMA
Laboratories Div
IMDELLTRA (tarlatamab-dlle)
ANTINEOPLASTIC - IMMUNOTHERAPY, T-CELL ENGAGER · EXTENSIVE-STAGE SMALL CELL LUNG CANCER
AMGEN
ELREXFIO (elranatamab-bcmm)
ANTINEOPLASTIC - IMMUNOTHERAPY, T-CELL ENGAGER · MULTIPLE MYELOMA
U.S. PHARMACEUT
LYNOZYFIC (linvoseltamab-gcpt)
ANTINEOPLASTIC - IMMUNOTHERAPY, T-CELL ENGAGER · MULTIPLE MYELOMA
Regeneron Pharmaceuticals, Inc.
LUNSUMIO VELO (mosunetuzumab-axgb)
ANTINEOPLASTIC - IMMUNOTHERAPY, T-CELL ENGAGER · FOLLICULAR LYMPHOMA
GENENTECH